Valuation : Vista Pharmaceuticals Limited

Market Cap 376M 3.96M 3.42M 3.22M 2.93M 5.51M 5.54M 38.01M 14.8M 191M 14.88M 14.56M 634M P/E 2024
-10.3x
P/E 2025 -13.6x
Enterprise Value 443M 4.67M 4.02M 3.79M 3.45M 6.49M 6.52M 44.75M 17.42M 225M 17.52M 17.14M 747M EV / Sales 2024
7.63x
EV / Sales 2025 8.85x
Free-Float
22.51%
Yield 2024 *
-
Yield 2025 -
1 day+1.50%
1 week+1.00%
Current month-2.87%
1 month-7.31%
3 months-19.23%
6 months+5.00%
Current year-25.18%
1 week 5.8
Extreme 5.8
6.49
1 month 5.8
Extreme 5.8
7.28
Current year 5.71
Extreme 5.71
8.87
1 year 5.71
Extreme 5.71
10.75
3 years 5.71
Extreme 5.71
19.7
5 years 5.71
Extreme 5.71
19.7
10 years 4.51
Extreme 4.51
56.15
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Compliance Officer - 10/02/2024
Director TitleAgeSince
Chairman 76 02/01/2014
Director/Board Member 87 16/06/1993
Director/Board Member 76 02/02/2010
Change 5-day change 1-year change 3-year change Capi.($)
+1.50%+1.00%-38.92%-59.15% 3.89M
+0.14%+1.70%+23.42%+74.20% 48.77B
-1.61%-0.29%+51.58%+118.38% 40.67B
-1.16%+0.37%+15.87%+86.01% 12.27B
-0.72%+0.72%-9.97%+14.04% 12.11B
+0.57%+1.73%+31.59%+153.11% 9.28B
-1.75%-3.23%+23.87%+44.12% 7.55B
-0.42%+0.89%+28.21%+223.05% 7.35B
-0.62%-0.84%+44.70%-11.26% 7.3B
-0.13%-0.16%-40.47%+15.85% 5.25B
Average -0.43%-0.12%+12.99%+65.83% 15.06B
Weighted average by Cap. -0.65%+1.25%+27.28%+86.69%

Financials

2024 2025
Net sales 103M 1.08M 935K 880K 801K 1.51M 1.51M 10.4M 4.05M 52.33M 4.07M 3.98M 174M 101M 1.06M 916K 861K 785K 1.48M 1.48M 10.18M 3.96M 51.25M 3.99M 3.9M 170M
Net income -45.12M -475K -410K -386K -351K -661K -664K -4.56M -1.78M -22.95M -1.78M -1.75M -76.1M -46.49M -490K -423K -397K -362K -681K -685K -4.7M -1.83M -23.65M -1.84M -1.8M -78.41M
Net Debt 78.7M 829K 715K 673K 613K 1.15M 1.16M 7.95M 3.1M 40.04M 3.11M 3.05M 133M 66.71M 703K 606K 570K 520K 977K 982K 6.74M 2.62M 33.93M 2.64M 2.58M 113M
Logo Vista Pharmaceuticals Limited
Vista Pharmaceuticals Limited is an India-based company, which is engaged in the manufacturing of pharmaceutical products. The Company offers over the counter and prescription generic drug products consisting of tablets, capsules and liquids covering various therapeutic categories. The Company has its United States Food and Drug Administration (USFDA) approved manufacturing facility in India and its marketing and distribution center in United States. Its products include tablet dosage forms and capsule dosage forms. The Company's tablet dosage forms in United States market include sulfamethoxazole & trimethoprim (400/80 mg) and acetaminophen (500 mg) film coated. The Company's tablet dosage forms in Non-United States market include aspirin (300, 325 & 500 mg), atenolol (50 & 100 mg), cotrimoxazole (480 mg), captopril (25 & 50 mg) and frusemide (40 mg). Its capsule dosage forms in Non-United States market include indomethacin (25 mg), piroxicam (10 & 20 mg) and nifedipine (10 mg).
Employees
30
Date Price Change Volume
02/09/26 6.090 +1.50% 4,905
01/09/26 ₹6.000 -4.31% 5,939
31/08/26 ₹6.270 -1.10% 9,143
28/08/26 ₹6.340 +5.32% 8,559
27/08/26 ₹6.020 -0.17% 17,294
  1. Stock Market
  2. Stocks
  3. VISTAPH6 Stock